PFG Investments’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
FP
PFG Investments's MRNA Position: Q3 2024 in Review
PFG Investments sold out of Moderna (MRNA) in Q3 2024, closing a stake of 3,193 shares — an estimated $379K sold.
PFG Investments first reported a position in MRNA in Q1 2023 and held it in 5 quarters. The position peaked at $659K in Q1 2023. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.
- PFG Investments reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
- PFG Investments sold 3,193 Moderna shares in Q3 2024, an estimated $379K.
- PFG Investments first reported a position in Moderna in Q1 2023 and held it in 5 quarters.
- PFG Investments's Moderna position peaked at $659K in Q1 2023.
- 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.
Based on PFG Investments's 13F filing for Q3 2024, filed 24 Oct 2024.